Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008981 |
ID: | TCMBANKHE008981 |
植物拉丁名: |
|
功能与主治: | To eliminate inflammation, anticancer./Pharyngolaryngitis, carcinoma of esophagus, nasopharyngeal carcinoma. |
药用植物名: | 树舌 |
药用部位: | sporocarp |
TCM_ID_id: | 4724 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000199 | applanoxidic acid C | C30H38O8 | CC(CC(=O)CC(C)(C1=CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)O)C(=O)O | ||
| TCMBANKIN001591 | 24-methylcycloartanol ferulate | C41H62O4 | CC(C)C(C)CCC(C)C1CCC2(C1(CCC34C2CCC5C3(C4)CCC(C5(C)C)OC(=O)C=CC6=CC(=C(C=C6)O)OC)C)C | ||
| TCMBANKIN005521 | Ergosta-7,22-dien-3beta-yl palmitate | ergosta-7,22-dien-3β-yl palmitate; Ergosta-7,22-dien-3β-yl-palmitate | C44H76O2 | 637.07 | CCCCCCCCCCCCCCCC(=O)OC1CCC2(C3CCC4(C(C3=CCC2C1)CCC4C(C)C=CC(C)C(C)C)C)C |
| TCMBANKIN005727 | Ganoderenic acid G | ganoderenic acid G | C30H40O7 | 512.63 | CC(CC(=O)C=C(C)C1CC(C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C)O)C(=O)O |
| TCMBANKIN008944 | applanoxidic acid A | C30H40O7 | 512.6 g/mol | CC(CC(=O)C=C(C)C1CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)O)C(=O)O | |
| TCMBANKIN009926 | ergosta-7,22-dien-3-one | (22E,24R)-ergosta-7,22-dien-3 β-one; Ergosta-7,22-dien-3-one | C28H44O | 396.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CCC4C3(CCC(=O)C4)C)C |
| TCMBANKIN011125 | ergostatetra-4 , 6 , 8(14), 22-en-3-one | ||||
| TCMBANKIN011290 | Elfvingic acid G | C30H40O9 | 544.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C2(C(=O)CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)O)C(=O)O | |
| TCMBANKIN011791 | applanoxidic acid F | C30H38O7 | 510.6 g/mol | CC(CC(=O)C=C(C)C1CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)C(=O)O | |
| TCMBANKIN011951 | 7β-hydroxy-3,11,15,23-tetraoxolanosta-8,20 e(22)-dien-26-oicacid methyl ester | 7β-Hydroxy-3,11,15,23-tetraoxolanosta-8,20E(22)-dien-26-oic acid methyl ester | C31H42O7 | CC(CC(=O)C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)C(=O)OC | |
| TCMBANKIN012191 | applanoxidic acids | ||||
| TCMBANKIN012219 | Elfvingic acid E | C30H42O9 | 546.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(C5(C)CO)O)C)C)C)O)O)C(=O)O | |
| TCMBANKIN013983 | applanoxidic acid D | C30H40O8 | CC(CC(=O)CC(C)(C1=CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(C5(C)C)O)C)C)C)O)C(=O)O | ||
| TCMBANKIN014856 | 5α-ergost-7-en-3β-ol | ||||
| TCMBANKIN015566 | Elfvingic acid B | C30H40O8 | 528.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)O)O)C(=O)O | |
| TCMBANKIN016170 | Elfvingic acid C | C30H42O8 | 530.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(C5(C)C)O)C)C)C)O)O)C(=O)O | |
| TCMBANKIN016868 | ganoderma aldehyde | C16H14O6 | 302.28 g/mol | C=C(C=O)C1CCC2C(=O)C3=C(C=CC(=C3)O)OC2(C1=O)O | |
| TCMBANKIN016937 | ergosta-7,22-dien-3β-ol | 24-methylcholesta-7,22-dien-3β-ol; Ergosta-7,22-dien-3β-ol | 398.74 | CC(C)C(=C)CCC(C)C1CCC2C1(CCC3=C2CCC4C3(CCC(C4)O)C)C | |
| TCMBANKIN017221 | linoleic acid | (9E,12E)-octadeca-9,12-dienoate; AC1NYW3V; sodium (9E,12E)-octadeca-9,12-dienoate; BDBM22336; 9,12-octadecadienoate; linoleicacid | C18H31O2- | 279.4 g/mol | CCCCCC=CCC=CCCCCCCCC(=O)[O-] |
| TCMBANKIN017484 | (24S)-24-methyl-5α-cholest-7-ene-3β-ol | ||||
| TCMBANKIN018288 | 7β,20,23 ξ-trihydroxy-3,11,15-trioxolanosta-8-en-26-oicacid | C30H44O8 | |||
| TCMBANKIN020053 | applanoxidic acid B | C30H40O7 | CC(CC(=O)C=C(C)C1CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(C5(C)C)O)C)C)C)C(=O)O | ||
| TCMBANKIN020591 | Elfvingic acid A | C30H40O8 | 528.6 g/mol | CC(CC(=O)C=C(C)C1CC(C2(C1(C(C(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O | |
| TCMBANKIN022217 | 5α,8α-Peroxydehydrotumulosic acid | C31H46O6 | CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C24C=CC5(C3(CCC(C5(C)C)O)C)OO4)C)C)O)C(=O)O | ||
| TCMBANKIN022225 | methyl 16-epiquillate | C31H48O5 | CC1(CCC2(C(C1)C3=CCC4C5(CCC(C(C5CCC4(C3(CC2O)C)C)(C)C=O)O)C)C(=O)OC)C | ||
| TCMBANKIN022470 | 7β,23ξ-dihydroxy-3,11,15-trioxolanosta-8,-20e(22)-dien-26-oicacid | C30H42O7 | CC(CC(C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O)C(=O)O | ||
| TCMBANKIN022516 | applanoxidic acid H | C30H42O8 | 530.6 g/mol | CC(CC(=O)CC(C)(C1=CC(=O)C2(C1(C(C=C3C24C(O4)CC5C3(CCC(C5(C)C)O)C)O)C)C)O)C(=O)O | |
| TCMBANKIN022867 | 7β,23ξ-dihydroxy-3,11,15-trioxolanosta-8 , 20E(22)-dien-26-oic acid | ||||
| TCMBANKIN023692 | 2-Hydroxy-hexadecanoic acid | C16H32O3 | 272.42 | CCCCCCCCCCCCCCC(C(=O)O)O | |
| TCMBANKIN024430 | ganoderic acids | C30H44O3 | 452.7 g/mol | CC(CCC=C(C)C(=O)O)C1CCC2(C1(CC=C3C2=CCC4C3(CCC(=O)C4(C)C)C)C)C | |
| TCMBANKIN025267 | ergosta-4,6,8(14),22-tetraen-3-one(2) | ||||
| TCMBANKIN025676 | 24- methyl cholestane-7, 22- diene-3β- alcohol | ||||
| TCMBANKIN025927 | 2,5-dihydroxybisabola-3,10-diene | 224.38 | |||
| TCMBANKIN026800 | furanoganoderic acid | ||||
| TCMBANKIN030847 | ganoderenic acid F | C30H38O7 | 510.6 g/mol | CC(CC(=O)C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(=O)C4(C)C)C)C)C)C(=O)O | |
| TCMBANKIN031502 | Elfvingic acid F | C30H42O9 | 546.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(C5(C)C)O)CO)C)C)O)O)C(=O)O | |
| TCMBANKIN032703 | Ergosta-5 , 8 ,22-trien-3β , 15-diol | ||||
| TCMBANKIN032797 | applanoxidic acid E | C30H40O7 | 512.6 g/mol | CC(CC(=O)C=C(C)C1CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)O)C(=O)O | |
| TCMBANKIN033617 | applanoxidic acid G | C30H40O8 | 528.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)O)O)C(=O)O | |
| TCMBANKIN034261 | Elfvingic acid D | C30H42O9 | 546.6 g/mol | CC(CC(=O)CC(C)(C1=CC(C2(C1(C(=O)C=C3C24C(O4)CC5C3(CC(C(C5(C)C)O)O)C)C)C)O)O)C(=O)O | |
| TCMBANKIN034397 | Methyl ganoderate I | methyl ganoderate i; methyl (Z)-6-[(10S,13R,17S)-3,15-dihydroxy-4,4,10,13,14,17-hexamethyl-7,11-dioxo-1,2,3,5,6,12,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoate; AC1NSYEJ | C31H46O8 | 546.69 | CC(CC(=O)C=C(C)C1(CC(C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C)O)C)C(=O)OC |
| TCMBANKIN034766 | Elfvingic acid H | C30H42O8 | 530.6 g/mol | CC(CC(C=C(C)C1CC(C2(C1(C(=O)C=C3C24C(O4)CC(C3(C)CCC(=O)O)C(=C)C)C)C)O)O)C(=O)O | |
| TCMBANKIN036747 | (24s)-25-methoxycycloartane-3,beta,24,28-triol | 506.9 | |||
| TCMBANKIN037484 | Ganoderenic acid D | ganoderenic acid D | 512.63 | ||
| TCMBANKIN038364 | isoergosterone | C28H42O | 394.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C | |
| TCMBANKIN041080 | β-amyrin acetate | Acetic acid oleana-12-ene-3alpha-yl ester; b—Amyrin-acetate; beta-amyrin acetate; 3β-O-acetoxyolean-12-en- 28-oic acid; β- amyrin acetate; beta-amyrin acetate ; beta-Amyrin acetate | C32H52O2 | 468.75 | CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CC=C4C3(CCC5(C4CC(CC5)(C)C)C)C)C)C |
| TCMBANKIN042894 | methyl ganoderate H | methyl ganoderate h | C33H46O9 | 587 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)[C@@]([H])(OC(C([H])([H])[H])=O)[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C(=O)C([H])([H])[C@]([H])(C(OC([H])([H])[H])=O)C( [H])([H])[H])C([H])([H])C2=O)[C@@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN043071 | ganoderenic acid H | ganoderenicacid h | C30H40O7 | 512.63 | CC(CC(=O)C=C(C)C1CC(=O)C2(C1(CC(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)C)C)C(=O)O |
| TCMBANKIN043645 | Lucidone A | (3S,5R,7S,10S,13R,17S)-17-acetyl-3,7-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthrene-11,15-dione; lucidone a; AC1L44B5 | 402.52 | ||
| TCMBANKIN046883 | Methyl ganoderate AP | methyl 6-[(10S,12S,13R,17S)-12,15-dihydroxy-4,4,10,13,14-pentamethyl-3,7,11-trioxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-4-oxoheptanoate; AC1NSYEG | C31H44O9 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])(C(C(=O)[C@@]([H])(O[H])[C@](C([H])([H])[H])([C@@]([H])([C@@](O[H])(C([H])([H])[H])C([H])([H])C(C([H])([H])[C@]([H])(C([H])([H])[H])C(OC([H])([H])[H])=O)=O)C ([H])([H])[C@]2([H])O[H])[C@@]23C([H])([H])[H])=C3C(=O)C4([H])[H])[C@]4([H])C(C([H])([H])[H])(C([H])([H])[H])C1=O | |
| TCMBANKIN049506 | ganoderenic acid I | ganoderenicacid i | C30H42O7 | 514.65 | |
| TCMBANKIN049965 | 5α-hydroperoxy-eudesma-4(15),11-diene | C15H24O2 | |||
| TCMBANKIN059147 | ergosterin | ergosterol;24-Methylcholesta-5,7,22-trien-3beta-ol; 24alpha-Methyl-22E-dehydrocholestero; (3beta,22E)-Ergosta-5,7,22-trien-3-ol; (7S,9AR,11AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-9A,11A-DIMETHYL-1H,2H,3H,3AH,6H,7H,8H,9H,9BH,10H,11H-CYCLOPENTA[A]PHENANTHREN-7-OL; 45480_FLUKA; (24R)-Ergosta-5,7,22-trien-3b-ol; MEGxm0_000450; Ergosterin; 24R-Methylcholesta-5,7,22E-trien-3b-ol; 57-87-4; Ergosterol; ergosta-5,7,22E-trien-3beta-ol; (3beta)-Ergosta-5,7,22-trien-3-ol; C01694; 5,7,22-Ergostatrien-3beta-ol; AIDS064232; E6510_SIGMA; Provitamin D2; (22E)-Ergosta-5,7,22-trien-3.beta.-ol; A831651; ergosta-5,7,22-trienol; ergosta-5,7,22-trien-3 beta-ol; 24R-Methylcholesta-5,7,22E-trien-3beta-ol; ACon0_000429; ERG; ST073383; (3S,10R,13R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 24-Methylcholesta-5,7,22-trien-3b-ol; ACon1_000637; (3beta,2E)-Ergosta-5,7,22-trien-3-ol; Provitamine D2; AIDS-064232; 24a-Methyl-22E-dehydrocholesterol; ergosta-5,7,22-trien-3-ol; 47130U_SUPELCO; LMST01030093; (22E)-ergosta-5,7,22-trien-3beta-ol; ZINC04084618; (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; 3beta-Hydroxy-5,7,22-ergostatriene; CHEBI:16933; (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (22E,24S)-24-methylcholesta-5,7,22-trien-3beta-ol | C28H44O | 396.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C |
| TCMBANKIN059149 | Ergosterol peroxide | 2061-64-5; NSC31324; Ergosterol peroxide; 5.alpha.,8.alpha.-Ergosta-6,22-dien-3.beta.-ol, 5,8-epidioxy-; ERGOSTEROL-5,8-PEROXIDE; Ergosterol 5.alpha.,8.alpha.-epidioxide; Ergosta-6,22-dien-3-ol, 5,8-epidioxy-, (3.beta.,5.alpha.,8.alpha.,22E)-; Ergosterol endoperoxide; (3β,5α,8α,22E,24R)-5,8-Epidioxyergosta-6,22-dien-3-ol; 5,8-epidioxyergosta-6,22-dien-3-ol; Peroxyergosterol; ergosterol peroxide; 2061-64-5; ergosterolperoxide; dimethyl-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl][?]ol; (3.beta.,5.alpha.,8.alpha.,22E)-5,8-Epidioxyergosta-6,22-dien-3-ol | C28H44O3 | 428.6 g/mol | CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C24C=CC5(C3(CCC(C5)O)C)OO4)C |
| TCMBANKIN059312 | ganoderic acid AP | ganoderic acid a; ganoderic acid A; ganode-8-en-ricacid a | C30H44O7 | 516.67 | CC(CC(=O)CC(C)C(=O)O)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
| TCMBANKIN059313 | methyl-7-epiganoderate | methyl 6-[(10S,13R,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate; AC1NSYD7;methyl ganoderate a;methyl ganoderate A | C31H46O7 | 530.7 g/mol | CC(CC(=O)CC(C)C(=O)OC)C1CC(C2(C1(CC(=O)C3=C2C(CC4C3(CCC(=O)C4(C)C)C)O)C)C)O |
| TCMBANKIN059523 | (3β,8β, 14α, 21α)-26, 27-dinoronocerane-3, 8, 14, 21-tetrol | C28H50O4 | CC1(C2CCC(C(C2(CCC1O)C)CCC3C(CCC4C3(CCC(C4(C)C)O)C)O)O)C | ||
| TCMBANKIN059637 | alnusenone | C30H48O | 424.7 g/mol | CC1(CCC2(CCC3(C4CC=C5C(C4(CCC3(C2C1)C)C)CCC(=O)C5(C)C)C)C)C | |
| TCMBANKIN060140 | friedelan-3-one | C30H50O | 426.7 g/mol | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C | |
| TCMBANKIN060349 | 25(27)-ene-1β,2β,3β,4β,5β,7α-hexaol-spirost-6-one | C27H40O8 | CC1C2C(CC3C2(CCC4C3CC(=O)C5(C4(C(C(C(C5O)O)O)O)C)O)C)OC16CCC(=C)CO6 | ||
| TCMBANKIN060858 | 6-methylgingediacetate2 | C22H34O6 | 394.5 g/mol | CCCCCC(CC(CCC1=CC(=C(C=C1)OC)OC)OC(=O)C)OC(=O)C | |
| TCMBANKIN060958 | oleic acid;cis-oleic acid;oleinic acid | C18H34O2 | 282.46 | CCCCCCCCC=CCCCCCCCC(=O)O | |
| TCMBANKIN061091 | stearic acid | CH3(CH2)16COOH | 284.5 g/mol | CCCCCCCCCCCCCCCCCC(=O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab